Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01989052
Title Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Annick Desjardins
Indications

gliosarcoma

high grade glioma

glioblastoma

Therapies

Lomustine

Carboxyamidotriazole Orotate

Age Groups: adult
Covered Countries USA


No variant requirements are available.